Preventing ischaemic stroke - dipyridamole plus acetylsalicylic acid (Asasantin 200/25 Retard) launched

被引：0
|
作者：
不详
机构：
来源：
SOUTH AFRICAN MEDICAL JOURNAL | 1998年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：C175 / C175
页数：1
相关论文
共 40 条
  • [31] ENTERIC-COATED ACETYLSALICYLIC-ACID PLUS DIPYRIDAMOLE COMPARED WITH ANTICOAGULANTS IN THE PREVENTION OF ISCHEMIC EVENTS IN PATIENTS WITH TRANSIENT ISCHEMIC ATTACKS
    ERIKSSON, SE
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1985, 71 (06): : 485 - 493
  • [32] Results from the ESPRIT trial published in The Lancet confirm that combination of dipyridamole and acetylsalicylic acid (ASA) is superior to ASA alone in the prevention of recurrent stroke
    不详
    [J]. THROMBOSIS AND HAEMOSTASIS, 2006, 96 (01) : VII - VII
  • [33] EUROPEAN STROKE PREVENTION STUDY .2. A STUDY OF LOW-DOSE ACETYLSALICYLIC-ACID AND OF HIGH-DOSE DIPYRIDAMOLE IN SECONDARY PREVENTION OF CEREBROVASCULAR ACCIDENTS
    不详
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 1995, 2 (05) : 416 - 424
  • [34] Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial
    Dengler, Reinhard
    Diener, Hans-Christoph
    Schwartz, Andreas
    Grand, Martin
    Schumacher, Helmut
    Machnig, Thomas
    Eschenfelder, Christoph Cyrill
    Leonard, Joachim
    Weissenborn, Karin
    Kastrup, Andreas
    Haberl, Roman
    [J]. LANCET NEUROLOGY, 2010, 9 (02): : 159 - 166
  • [35] Pharmacokinetics and Pharmacodynamics of the Antiplatelet Combination Aspirin (Acetylsalicylic Acid) Plus Extended-Release Dipyridamole Are Not Altered by Coadministration with the Potent CYP2C19 Inhibitor Omeprazole
    Elliot Offman
    Michael J. Schobelock
    Rolf Brickl
    Cam P. VanderMaelen
    Jerome Ehrlich
    Wolfgang Eisert
    [J]. American Journal of Cardiovascular Drugs, 2013, 13 : 113 - 120
  • [36] Pharmacokinetics and Pharmacodynamics of the Antiplatelet Combination Aspirin (Acetylsalicylic Acid) Plus Extended-Release Dipyridamole Are Not Altered by Coadministration with the Potent CYP2C19 Inhibitor Omeprazole
    Offman, Elliot
    Schobelock, Michael J.
    Brickl, Rolf
    VanderMaelen, Cam P.
    Ehrlich, Jerome
    Eisert, Wolfgang
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2013, 13 (02) : 113 - 120
  • [37] Incremental cost-effectiveness of dipyridamole + acetylsalicylic acid in secondary prevention of ischemic noncardioembolic stroke [Inkrementelle Kosteneffektivität von Dipyridamol + Acetylsalicylsäure in der Sekundärprävention bei ischämischem nichtkardioembolischem Schlaganfall]
    Claes C.
    Mittendorf T.
    Grond M.
    Von Der Schulenburg J.-M.G.
    [J]. Medizinische Klinik, 2008, 103 (11) : 778 - 787
  • [38] Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial:: a double-blind, active and placebo-controlled study
    Dienert, Hans-Christoph
    Saccot, Ralph L.
    Yusuft, Salim
    Cotton, Daniel
    Ounpuu, Stephanie
    Lawton, William A.
    Palesch, Yuko
    Martin, Renee H.
    Albers, Gregory W.
    Bath, Philip
    Bornstein, Natan
    Chan, Bernard P. L.
    Chen, Sien-Tsong
    Cunha, Luis
    Dahlof, Bjorn
    De Keyser, Jacques
    Donnan, Geoffrey A.
    Estol, Conrado
    Gorelick, Philip
    Gu, Vivian
    Hermansson, Karin
    Hilbrich, Lutz
    Kaste, Markku
    Lu, Chuanzhen
    Machnig, Thomas
    Pais, Prem
    Roberts, Robin
    Skvortsova, Veronika
    Teal, Philip
    Toni, Danilo
    VanderMaelen, Cam
    Voigt, Thor
    Weber, Michael
    Yoon, Byung-Woo
    [J]. LANCET NEUROLOGY, 2008, 7 (10): : 875 - 884
  • [39] Comparison of two antiplatelet treatment strategies (combination of dipyridamole MR and acetylsalicylic acid vs. clopidogrel) and telmisartan therapy vs. placebo in post-stroke patients in prevention of further cerebrovascular event - PRoFESS Study assumptions
    Szczepaniak-Chichel, Ludwina
    [J]. ARTERIAL HYPERTENSION, 2007, 11 (04): : 369 - 373
  • [40] Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study (vol 7, pg 875, 2008)
    Diener, H-C
    Sacco, R. L.
    Yusuf, S.
    [J]. LANCET NEUROLOGY, 2008, 7 (11): : 985 - 985
1234